Beta thalassemia major
Cooley’s anemia
Homozygous beta thalassemia
Severe beta thalassemia
Thalassemia intermedia
Thalassemia major
Beta^+^ thalassemia
Beta^0^ thalassemia
Hemoglobin c beta^+^ thalassemia
Hemoglobin c beta^0^ thalassemia
Hemoglobin d beta^+^ thalassemia
Hemoglobin d beta^0^ thalassemia
Hemoglobin e beta^+^ thalassemia
Hemoglobin e beta^0^ thalassemia
Hgb c beta plus thalassemia
Hgb c beta zero thalassemia
Hgb d beta plus thalassemia
Hgb d beta zero thalassemia
Hgb e beta plus thalassemia
Hgb e beta zero thalassemia
Homozygous beta thalassemia
Thalassemia, beta
Thalassemia, beta plus
Thalassemia, beta zero
Thalassemia, beta, homozygous
A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin a synthesis in the heterozygous form thalassemia minor), which is asymptomatic, while in the homozygous form thalassemia major, cooley’s anemia, mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin a synthesis is absent.
An autosomal recessive disorder that affects the production of beta polypeptide chains which are necessary for the hemoglobin synthesis. Anemia and failure to thrive are characteristic features.
D56.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM D56.1 became effective on October 1, 2022.
This is the American ICD-10-CM version of D56.1 – other international versions of ICD-10 D56.1 may differ.